Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs IONS✓SelectedUSD · IONSGSK vs IONS performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs IONS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+97.1%
IONS return
-41.2%
Excess return
+138.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioIONSExcessAlpha
1D-0.1%-2.4%+2.2%+0.1%
7D-5.3%-8.5%+3.2%-4.5%
30D-3.7%-40.0%+36.3%+1.0%
3M-7.3%-54.8%+47.5%0.0%
6M-4.2%-64.6%+60.3%+5.4%
YTD+0.9%-66.4%+67.3%+11.5%
1Y+7.3%-63.6%+70.9%+17.6%
3Y+52.7%-46.5%+99.2%+57.5%
5Y+40.1%-16.9%+57.0%+35.4%
All+97.1%-41.2%+138.2%+92.8%

Cumulative growth

Daily Returns

Daily percentage return beside IONS.

Daily Out/Under-Performance

Portfolio return minus IONS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × IONS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded IONS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling